Patents by Inventor Rongqing ZHANG

Rongqing ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12247087
    Abstract: The present application provides a biological active peptide from seawater pearl, the sequence of which is Ile-Pro-Ser-Thr-Thr-Pro-Phe-Pro-Ser-Thr-Thr-Val-Ala-Thr-Thr-Thr-Met, and the name of which is SCOL polypeptide. The biological active peptide can improve an ACE2 enzyme activity to 3.76 times, and can be applied in preparation of a drug improving an ACE2 activity, treating hypertension, anti-heart failure, anti-tissue fibrosis, anti-inflammation, and type 2 diabetes mellitus and the complication thereof, and relieving neuropathic pain. The biological active peptide can be specifically bound to the ACE2, effectively inhibits the 65% binding between novel coronavirus S protein and the ACE2, can be applied in preparation of an anti-coronavirus infection drug as an inhibitor, and specifically applied in preparation of anti-novel coronavirus drug.
    Type: Grant
    Filed: January 18, 2024
    Date of Patent: March 11, 2025
    Assignees: ZHEJIANG QINGRONG BIOTECHNOLOGY DEVELOPMENT CO., LTD, YANGTZE DELTA REGION INSTITUTE OF TSINGHUA UNIVERSITY, ZHEJIANG
    Inventors: Xiaojun Liu, Rongqing Zhang, Jing Zhang, Zehui Yin, Liping Yao, Zhen Zhang
  • Publication number: 20240376150
    Abstract: The present application provides a biological active peptide from seawater pearl, the sequence of which is Ile-Pro-Ser-Thr-Thr-Pro-Phe-Pro-Ser-Thr-Thr-Val-Ala-Thr-Thr-Thr-Met, and the name of which is SCOL polypeptide. The biological active peptide can improve an ACE2 enzyme activity to 3.76 times, and can be applied in preparation of a drug improving an ACE2 activity, treating hypertension, anti-heart failure, anti-tissue fibrosis, anti-inflammation, and type 2 diabetes mellitus and the complication thereof, and relieving neuropathic pain. The biological active peptide can be specifically bound to the ACE2, effectively inhibits the 65% binding between novel coronavirus S protein and the ACE2, can be applied in preparation of an anti-coronavirus infection drug as an inhibitor, and specifically applied in preparation of anti-novel coronavirus drug.
    Type: Application
    Filed: January 18, 2024
    Publication date: November 14, 2024
    Inventors: Xiaojun LIU, Rongqing Zhang, Jing Zhang, Zehui Yin, Liping Yao, Zhen Zhang
  • Patent number: 9491025
    Abstract: A transmitting end of an Orthogonal Frequency-Division Multiplexing (OFDM) wireless communication system may generate a training sequence and attach the training sequence to a data sequence that contains information data. A receiving end of the OFDM wireless communication system may identify a starting position of the data sequence and further extract the data sequence.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: November 8, 2016
    Assignee: EMPIRE TECHNOLOGY DEVELOPMENT LLC
    Inventors: Xiang Cheng, Rongqing Zhang
  • Publication number: 20160056988
    Abstract: A transmitting end of an OFDM wireless communication system may generate a training sequence and attach the training sequence to a data sequence that contains information data. A receiving end of the OFDM wireless communication system may identify a starting position of the data sequence and further extract the data sequence.
    Type: Application
    Filed: July 25, 2013
    Publication date: February 25, 2016
    Inventors: Xiang CHENG, Rongqing ZHANG
  • Patent number: D907026
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: January 5, 2021
    Inventor: Rongqing Zhang
  • Patent number: D936644
    Type: Grant
    Filed: September 1, 2019
    Date of Patent: November 23, 2021
    Inventor: Rongqing Zhang